Screener
Regeneron Pharmaceuticals REGN Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's book value per share?
- Regeneron Pharmaceuticals (REGN) reported book value per share of $299.16 in Q2 2026.
- How has Regeneron Pharmaceuticals's book value per share changed year-over-year?
- Regeneron Pharmaceuticals's book value per share increased by 8.5% year-over-year, from $275.68 to $299.16.
- What is the long-term trend for Regeneron Pharmaceuticals's book value per share?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's book value per share has grown at a 24.6% compound annual growth rate (CAGR), from $95.79 to $287.82.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Regeneron Pharmaceuticals's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude